Liposomal formulation of gp41 derivative with adjuvant MPLA: Vaccine design, immunogenicity in animals and safety in humans

Research output: Contribution to conferencePosterpeer-review

92 Downloads (Pure)
Original languageEnglish
Publication statusAccepted - 2012

Cite this